Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.597
Abstract: Roxadustat is a hypoxia‐inducible factor prolyl hydroxylase inhibitor in late‐stage clinical development for the treatment of anemia in chronic kidney disease. Spherical carbon adsorbent (SCA) is used in patients with chronic kidney disease and has…
read more here.
Keywords:
pharmacokinetics roxadustat;
time;
drug;
effect ... See more keywords